
FDA Approves Donislecel for Type 1 Diabetes Treatment
Lantidra: A New Horizon in Type 1 Diabetes Management For anyone involved in healthcare, particularly within endocrinology, the U.S. Food and Drug Administration’s (FDA) recent approval of Donislecel, now known as Lantidra, feels like a […]